Proxima Investments specializes in the management of investment portfolios for a variety of clients in Israel and abroad.
Business Model: Consulting
Revenue: $10M
Employees: 2-10
Address:
City:
State:
Zip:
Country:
Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra&s;anan and is based in Tel Aviv, Israel.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2023 | Immune-Onc Therapeutics | Series B | 25M |
11/2017 | Cygnus Biosciences | Series B | 19.6M |
4/2018 | Yidianling | Series A | - |
12/2018 | Cryofocus Biotech | Series A | 2.9M |
12/2020 | Singlera Genomics | Series B | 0 |
1/2012 | BuzzDoes | Seed Round | 750k |
6/2011 | Soluto | Series B | 10.2M |
5/2021 | Jenscare Biotech | Venture Round | - |
1/2008 | Soluto | Seed Round | 1.6M |
5/2018 | HiFiBiO | Series B | 37.5M |
12/2021 | Great Bay Bio | Series A | 0 |
12/2021 | Yidianling | Series B | 31.4M |
2/2021 | Bioelectronica | Series A | - |
8/2018 | Yidianling | Series A | 2.9M |
8/2019 | AccuMedical | Series A | - |
1/2019 | ickor Medical | Series A | 0 |
11/2009 | Soluto | Series A | 6.2M |
7/2022 | VerImmune | Seed Round | 0 |
7/2022 | VerImmune | Seed Round | 0 |
12/2021 | Yidianling | Series B | 0 |
12/2021 | Great Bay Bio | Series A | 0 |
5/2021 | Jenscare Biotech | Venture Round | - |
2/2021 | Bioelectronica | Series A | - |
12/2020 | Singlera Genomics | Series B | 0 |
8/2019 | AccuMedical | Series A | - |
1/2019 | ickor Medical | Series A | 0 |
12/2018 | Cryofocus Biotech | Series A | 0 |
8/2018 | Yidianling | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|